- Home
- LPCN vs SYNX Comparison
LPCN vs SYNX Comparison
Compare LPCN & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SYNX
- Stock Information
- Founded
- LPCN 1997
- SYNX 2005
- Country
- LPCN United States
- SYNX Israel
- Employees
- LPCN N/A
- SYNX N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SYNX
- Sector
- LPCN Health Care
- SYNX
- Exchange
- LPCN Nasdaq
- SYNX Nasdaq
- Market Cap
- LPCN 19.4M
- SYNX 20.8M
- IPO Year
- LPCN N/A
- SYNX 2024
- Fundamental
- Price
- LPCN $3.38
- SYNX $3.85
- Analyst Decision
- LPCN Strong Buy
- SYNX
- Analyst Count
- LPCN 1
- SYNX 0
- Target Price
- LPCN $10.00
- SYNX N/A
- AVG Volume (30 Days)
- LPCN 33.0K
- SYNX 3.2K
- Earning Date
- LPCN 03-06-2025
- SYNX 10-02-2024
- Dividend Yield
- LPCN N/A
- SYNX N/A
- EPS Growth
- LPCN N/A
- SYNX N/A
- EPS
- LPCN N/A
- SYNX N/A
- Revenue
- LPCN $7,922,926.00
- SYNX $9,893,000.00
- Revenue This Year
- LPCN N/A
- SYNX $52.34
- Revenue Next Year
- LPCN N/A
- SYNX N/A
- P/E Ratio
- LPCN N/A
- SYNX N/A
- Revenue Growth
- LPCN N/A
- SYNX 18.05
- 52 Week Low
- LPCN $3.20
- SYNX $2.10
- 52 Week High
- LPCN $11.79
- SYNX $6.49
- Technical
- Relative Strength Index (RSI)
- LPCN 30.99
- SYNX 45.82
- Support Level
- LPCN $3.42
- SYNX $3.60
- Resistance Level
- LPCN $3.62
- SYNX $4.10
- Average True Range (ATR)
- LPCN 0.26
- SYNX 0.26
- MACD
- LPCN -0.02
- SYNX -0.04
- Stochastic Oscillator
- LPCN 1.61
- SYNX 47.59
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.